Skip to content

Annexon ANNX Total Assets

Total Assets at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$40.87B+8.9%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.25B+258%
Omeros logo
OmerosOMER
$286.17M+21.7%
Vor Biopharma logo
Vor BiopharmaVOR
$506.75M+364%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$402.98M-30.5%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$763.27M+198%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$868.37M+233%
Enterprise value$718.59M+274%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's total assets?
Annexon (ANNX) reported total assets of $262.89M in Q1 2026.
How has Annexon's total assets changed year-over-year?
Annexon's total assets decreased by 13.2% year-over-year, from $303.03M to $262.89M.
What is the long-term trend for Annexon's total assets?
Over 5 years (2020 to 2025), Annexon's total assets has grown at a -4.9% compound annual growth rate (CAGR), from $355.95M to $277.57M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.